MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC)

Author:

Gong Meng1,Shen Fujin1,Li Yang1,Hong Li1,Ming Lei1

Affiliation:

1. Renmin Hospital of Wuhan University

Abstract

AbstractMixed pedigree kinase 4 (MLK4) is a member of the serine/threonine kinases mixed pedigree kinase (MLKs) family. Few reports on immune-related targets in Cervical squamous cell carcinoma and endocervical adenocarcinoma CESC, and the role of MLK4 in cervical cancer remains to be studied. The expression of MLK4 in CESC was analyzed by TCGA database, and the effect of MLK4 on immune invasion was evaluated. Tissue microarray was used to verify the expression of MLK4 in CESC patients, and it was found that MLK4 was significantly overexpressed in CESC, and significantly correlated with CESC grade. Multiple analysis algorithms showed that the high expression of MLK4 was negatively correlated with immune cell infiltration in CESC. Analysis showed that MLK4 expression was negatively correlated with the infiltration of various immune cells including CD8 + T cells, and MLK4 mRNA expression was positively correlated with immune checkpoints PD-L1,CTLA4, LAG3, and negatively correlated with immune promotion genes CD86 and CD80. Furtherly, In vitro assays were conducted to identify the biological behavior of MLK4 in C33A cells. The downregulation of MLK4 resulted in reduced cell proliferation and invasion in C33A cells, as revealed by the EDU and transwell assays. QPCR results show that knock down MLK4 would inhibit the expression of classical biochemical markers CEA、AFP and HCG. Therefore, MLk4 may play a critical role in Cervical cancer.

Publisher

Research Square Platform LLC

Reference24 articles.

1. A Review of Cervical Cancer: Incidence and Disparities;Buskwofie A;J Natl Med Assoc,2020

2. Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates;Couvreur K;BMC Cancer,2018

3. Cervical Carcinoma: Oncobiology and Biomarkers;Volkova LV;Int J Mol Sci,2021

4. ANXA2 is a potential marker for the diagnosis of human cervical cancer;Wang Z;Biomark Med,2021

5. Ma H, Liu Z, Li H, Guo X, Guo S, Qu P, et al. Bioinformatics Analysis Reveals MCM3 as an Important Prognostic Marker in Cervical Cancer. Comput Math Methods Med 2021; 2021:8494260.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3